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Pregnancy-associated malaria is a major health problem, which mainly affects primigravidae living in malaria endemic
areas. The syndrome is precipitated by accumulation of infected erythrocytes in placental tissue through an interaction
between chondroitin sulphate A on syncytiotrophoblasts and a parasite-encoded protein on the surface of infected
erythrocytes, believed to be VAR2CSA. VAR2CSA is a polymorphic protein of approximately 3,000 amino acids forming
six Duffy-binding-like (DBL) domains. For vaccine development it is important to define the antigenic targets for
protective antibodies and to characterize the consequences of sequence variation. In this study, we used a
combination of in silico tools, peptide arrays, and structural modeling to show that sequence variation mainly occurs in
regions under strong diversifying selection, predicted to form flexible loops. These regions are the main targets of
naturally acquired immunoglobulin gamma and accessible for antibodies reacting with native VAR2CSA on infected
erythrocytes. Interestingly, surface reactive anti-VAR2CSA antibodies also target a conserved DBL3X region predicted
to form an a-helix. Finally, we could identify DBL3X sequence motifs that were more likely to occur in parasites isolated
from primi- and multigravidae, respectively. These findings strengthen the vaccine candidacy of VAR2CSA and will be
important for choosing epitopes and variants of DBL3X to be included in a vaccine protecting women against
pregnancy-associated malaria.
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Introduction
Individuals living in areas with high Plasmodium falciparum
transmission acquire immunity to malaria over time and
adults have markedly reduced risk of getting severe disease
[1]. Pregnant women constitute an important exception to
this rule, and this has severe consequences for both mother
and child [2]. Pregnancy-associated malaria (PAM) is charac-
terized by selective accumulation of P. falciparum in the
intervillous blood spaces of the placenta [3,4]. The main
pathophysiological consequences of PAM are delivery of low
birth weight babies and maternal anaemia [5]. In areas of high
parasite transmission PAM affects mainly primigravidae as
immunity is acquired as a function of parity [2]. Parasite
sequestration in the placenta is mediated by an interaction
between chondroitin sulphate A (CSA) on the syncytiotro-
phoblasts and proteins expressed on the surface of infected
erythrocytes [6]. VAR2CSA, a single and uniquely structured
molecule belonging to the Plasmodium falciparum erythrocyte
membrane protein 1 (PfEMP1) family, is currently believed to
be the main parasite ligand for placental binding [7]. Var2csa
is markedly up-regulated in P. falciparum selected in vitro to
bind to CSA [7] and in parasites isolated from the placenta
[8]. Antibodies to the surface-expressed VAR2CSA are
acquired by women exposed to malaria during pregnancy
[9,10], and high levels of anti-VAR2CSA antibodies at delivery
are associated with protection from low birth weight [9].
Furthermore, it has been demonstrated that targeted
disruption of var2csa results in the loss of [11], or a marked
reduction [12] in the ability of parasites to adhere to CSA.
Based on these ﬁndings, VAR2CSA is recognized as the
leading PAM vaccine candidate; however, var2csa is a
polymorphic gene and the sequence variation between genes
from different parasites ranges from 10%–30% at the nucleic
acid level [7,13]. It is thus a major challenge for vaccine
development to characterize the importance of the sequence
variation and to deﬁne smaller epitopes that can be used in a
vaccine to protect women against PAM. This study had two
objectives. Firstly, to characterize the epitopes of the CSA-
binding Duffy-binding-like (DBL) 3X domain of VAR2CSA,
which are recognized by naturally acquired antibodies.
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Secondly, to analyze the degree and consequences of
sequence variation and selection pressure within the var2csa
subfamily, using the var2csa cDNA sequences of a large
number of fresh placental parasite isolates. These studies
would also test the validity of B cell epitope predictions and
structural modeling of the DBL3X domain.
Results/Discussion
Recombinant VAR2CSA DBL3X Binds CSA and the Affinity
Depends on the Primary Amino Acid Sequence
It has previously been shown that DBL3X expressed on the
surface of Chinese hamster ovary cells binds CSA in vitro [14].
However, it is important to test the CSA-binding properties
of secreted VAR2CSA proteins produced in expression
systems that could allow for larger-scale production of a
vaccine. For this study, recombinant HIS-tagged proteins
were produced in Baculovirus-transfected insect cells and
binding to CSA was determined in an enzyme-linked
immunosorbent assay (ELISA) system. It has previously been
suggested that the FCR3 DBL3X domain binds CSA, whereas
the 3D7 DBL3X domain does not [14]. We found that both
variants had afﬁnity to CSA and that the 3D7 variant
exhibited the strongest binding. Binding of both FCR3 and
3D7 DBL3X was concentration-dependent (Figure 1A) and
could be inhibited by soluble CSA in a dose-dependant
manner (Figure 1B).
The Structure of the VAR2CSA DBL3X Domain Can Be
Modeled on the Basis of the Structure of the DBL Domains
of Erythrocyte-Binding Protein-175
Recently, the structures of the two DBL domains (F1 and
F2) of erythrocyte-binding protein (EBA)-175 and a DBL
domain in Plasmodium knowlesi (Pk)a-DBL were solved [15,16].
Using the crystal structure of EBA-175 F1 (Protein Data Bank
code 1ZRO) as template, a three-dimensional model of
DBL3X VAR2CSA was constructed by comparative modeling
on the basis of the 3D7 sequence (Figure 1C). The sequence
identity between DBL3X and EBA-175 F1 was 28%. From
sequence alignments of DBL3X, Pka-DBL, and EBA-175
(Figure S1) it was apparent that a number of cysteines were
conserved, and ten of these from DBL3X aligned with
cysteines which form disulﬁde bridges in the determined
structures of EBA-175 [15] and Pka-DBL [16]. In addition, we
identiﬁed 34 buried hydrophobic residues in EBA-175 F1,
EBA-175 F2, and Pka-DBL, which corresponded to hydro-
phobic residues buried in the DBL3X model (Figure S1).
Compared to EBA-175 F1, a number of insertions were found
in DBL3X, and the majority of these were predicted to have
coil secondary structure (Figure 1C). One of the insertions in
DBL3X (L1: R56-I63) was found to align structurally next to a
region in Pka-DBL, which is described as a ﬂexible linker with
an experimentally determined proteolytic cleavage site [16].
A second insertion (L2: N1417-E1430) was aligned in a loop
region where two residues were missing structural informa-
tion in the structure of EBA-175 F1 [15], which also indicates
high ﬂexibility. Thus, the alignment of DBL3X to the solved
DBL domain structures seems to match characteristics such
as disulﬁde-bridges, stabilizing hydrophobic interactions, and
ﬂexible loop regions. These ﬁndings suggest that VAR2CSA
DBL3X has the same basic structure as the solved DBL
structures [15–17] in spite of the extensive sequence
variation. The ability of proteins to form similar structures
despite marked sequence variation has also been described
for the VSG molecules covering the surface of Trypanosomes
[18,19].
Sequence Variation within the var2csa Family Is Present as
Small Hypervariable Blocks and Parasite Diversity Is Similar
on a Local and Global Scale
Var2csa is a relatively conserved var gene carried by all P.
falciparum genomes; however, sequence polymorphisms are
present in the gene. In a previous study, it was established
that var2csa is transcribed at high levels by placental parasites
isolated at delivery from Senegalese women [8,20]. Using
cDNA from 24 placentas from that study, the region encoding
DBL3X of var2csa was cloned and sequenced. A multiple
alignment of 43 sequences showed that the average nucleo-
tide diversity was low (p¼ 8.48% 6 0.37%, see Materials and
Methods for details) reﬂecting a limited inter-parasite
diversity in these isolates collected from a geographically
small and well-deﬁned area of West Africa. To test whether
the Senegalese placental DBL3X sequences represented a
monophyletic group compared to non-Senegalese DBL3X
sequences, a phylogenetic tree, which included VAR2CSA
DBL3X sequences available in GenBank, was constructed
(Figure 2). These non-Senegalese sequences included four
lab-strain parasites with different geographic origins (DD2
from Laos, MC from Thailand, IT4 from Brazil, and 3D7 with
unknown origin) and 21 sequences from a sequencing study
from Malawi [21]. The four database sequences and the
Malawi sequences were scattered evenly in the tree indicating
that the Senegalese sequences were representative for the
var2csa repertoire in general and that parasite nucleotide
diversity is similar on a local and global scale. It is also
apparent that there is no clear subgrouping within the
DBL3X sequences. The protein alignment of the DBL3X
sequences (Figure 3A) suggested that DBL3X could be divided
into four relatively conserved regions (C1–4) separated by
three shorter variable regions (V1–3). When the variable
regions were mapped to the 3-D model (Figure 3B), V1 and
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Synopsis
Pregnancy-associated malaria caused by Plasmodium falciparum is
characterized by the accumulation of parasite-infected red blood
cells in the placenta and is a major health problem in Africa.
VAR2CSA is a parasite protein expressed on the surface of malaria-
infected red blood cells and mediates the binding to the placental
receptor, chondroitin sulphate A. It is believed that a vaccine based
on VAR2CSA will protect pregnant women against the adverse
effects of pregnancy-associated malaria. However, due to the size
and polymorphism of VAR2CSA it is required to define smaller
regions that can be included in a vaccine and to analyze the degree
and consequences of sequence variation to ensure a broadly
protective immune response. The authors have characterized the
chondroitin sulphate A-binding DBL3X domain of VAR2CSA with
regard to epitopes targeted by naturally acquired antibodies and
the influence of sequence variation by bioinformatics and exper-
imental data based on a VAR2CSA peptide array. They identify both
variable and conserved surface-exposed epitopes that are targets of
naturally acquired immunoglobulin gamma in pregnant women
with placental malaria. These findings will be imperative for
choosing epitopes and variants of DBL3X to be included in a
vaccine protecting pregnant women against malaria.
V3 were part of ﬂexible loops, whereas V2 included another
ﬂexible loop but also extended into a helical region. The
length of V1 and V3 varied between sequences and the 3D7
sequence was relatively short in both regions.
VAR2CSA Sequence Motifs Can Be Linked to the Parity of
the Infected Women
We have previously shown that the expression of certain
var genes is associated with severe malaria in young children
[22] and suggested that var gene expression is hierarchically
structured. This could occur because the progeny of parasites
expressing var gene products that mediate the most efﬁcient
sequestration outgrow the progeny of parasites expressing a
molecule mediating less efﬁcient binding [22–24]. A similar
process could shape the expression of molecules mediating
binding in the placenta. If that was the case, it would be
predicted that a systematic difference between molecules
mediating binding in primigravidae and multigravidae
women could be detected in areas of high P. falciparum
transmission where women are exposed to several parasite
clones during pregnancy [25]. This was addressed by
calculating the Kullback-Leibler distance between 21 VAR2-
CSA sequences originating from primigravidae and 21
sequences from multigravidae. The overall cumulated Kull-
back-Leibler distance (DKL) between sequences from the
primigravidae and the multigravidae was higher than for
Figure 1. Recombinant DBL3X VAR2CSA Binds CSA and the Structure of the Domain Can Be Modeled on the Basis of the Structure of the DBL Domains
of EBA-175
(A) Binding assay. DBL3X binds to CSA in a protein concentration-specific manner. ELISA plates were coated with soluble CSA and binding of
recombinant proteins at different concentrations was determined. DBL3X from 3D7 shows better binding compared to DBL3X from FCR3. The non-CSA
binding VAR2CSA DBL4e was included as a control. Results are the mean of three binding assays and the error bars indicate the standard deviation.
(B) Inhibition assay. Recombinant DBL3X proteins (7 lg/ml) were preincubated with increasing amounts of soluble CSA, and binding to CSA-coated
plates was determined. Binding of DBL3X is dose-dependently inhibited by soluble CSA. Results are the mean of four inhibition binding assays and error
bars indicate the standard deviation.
(C) Model of DBL3X using EBA-175 as template. The figure shows a superposition of the EBA-175 F1 domain in light blue and the DBL3X (PFL0030c
amino acids 1,217–1,559) model in yellow with insertions highlighted in red. Arrows indicate insertions, which align with flexible loop regions in Pka-
DBL (L1) and EBA-175 F1 (L2). Side chains of glycan-binding residues in EBA-175 F1 are shown in black. Arrow 3 indicates the corresponding Pka-DBL
Duffy antigen receptor for chemokine-binding site.
doi:10.1371/journal.ppat.0020124.g001
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randomly chosen groupings of the sequences (p¼0.0075). The
DKL was also calculated for each position in the alignment to
determine which polymorphisms contributed to the differ-
ence between the sequence of parasites from primi- and
multigravidae women and visualized in a Kullback-Leibler
sequence logo (Figure 4A). This implicated two stretches of
amino acids in positions 135–175 and 233–245 located in the
V2 and V3 regions, respectively. The region from position
158 to 162 was of special interest since the motif ‘‘EIEKD’’ was
mainly found in primigravidae and the motif ‘‘GIEGE’’
mainly in the multigravidae (Table 1). Intermediate motifs
like ‘‘(G/E)IERE’’ where the fourth position had changed from
lysine to arginine were also found, implying that the following
evolutionary pathway may have been operating: lysine (AAA
or AAG) $ arginine (AGG) $ glycine (GGG). The change
from glutamate and lysine/arginine, which have large charged
side chains, into glycine without a side chain, could result in
marked functional and antigenic changes. Thus, it was
interesting that positions 1, 4, and 5 in the motif (position
158, 161, and 162) were predicted to be surface-exposed in
the structural model, which was also the case for all of the
other amino acid positions in V2 that differed signiﬁcantly in
the Kullback-Leibler sequence logo (Figure 4B and 4C). The
ﬁnding that parasites expressing the EIEKD motif were more
prevalent in primigravidae than in multigravidae women
(Table 1, Chi-square test: p , 0.001) could indicate that these
parasites have a biological advantage in women experiencing
their ﬁrst pregnancy and that parasites expressing the other
motifs (G/EIERE or GIEGE) have an advantage in women who
have been pregnant before. This could arise because parasites
carrying the EIEKD motif are the most efﬁcient mediators of
binding and therefore dominate in women with limited
Figure 2. Phylogenetic Relationship between Different VAR2CSA DBL3X Sequences
Bayesian inference tree of 43 placental cDNA sequences from Senegal (blue), 21 Malawian sequences (orange), and database sequences from four
isolates (green) of different geographic origin. The posterior probability of the clades is shown at the branches.
doi:10.1371/journal.ppat.0020124.g002
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immunity against PAM. As immunity develops against these
parasite forms, parasites expressing other motifs that are less
efﬁcient in binding but not serologically cross-reactive take
over. Interestingly, a monoclonal Ghanaian ﬁeld isolate
undergoing full genome sequencing at the Sanger Institute
has two copies of var2csa, one with the EIEKD motif and one
with the GIEGE. Although the functional background for the
observed phenomenon is presently not clear, the systematic
sequence variation at positions predicted to be surface-
exposed between parasites from primi- and multigravidae
women strengthen the concept that VAR2CSA is the main
parasite ligand for sequestration of malaria parasites in the
placenta.
VAR2CSA Is Under both Positive and Purifying Selection
A recent study has suggested that sequence polymorphisms
in a region of VAR2CSA upstream to DBL3X largely are due
to positive natural selection pressure [13]. To further
investigate the nature of sequence diversity in var2csa, the
dN/dS ratios (dN, rate of non-synonymous mutations per
non-synonymous site and dS, the rate of synonymous
mutations per synonymous site) for DBL3X were calculated
on the basis of the sequenced DBL3X domains. A dN/dS ,1
indicates that the position is under negative or purifying
selection pressure leading to conservation of the residue,
while dN/dS .1 suggests positive or diversifying selection
pressure, and suggests that amino acid changes are evolutio-
narily advantageous at the position. Purifying selection was
mainly found in the conserved regions C1–4 and it was
especially pronounced in the C2 and C4 regions, although
single sites were observed to be under diversifying selection
(Figure 5A). Several blocks appeared to be under strong
diversifying selection and these appeared most prominently
in regions V1, V2, and V3. It is interesting to note that
residues under diversifying selection mainly were situated in
regions predicted to be surface-exposed and concentrated on
one side of the molecule (Figure 5D and 5E). The two DBL
domains of EBA-175 are predicted to form a reverse
handshake dimer with the F1 domain of each molecule
interacting with F2 of the other [15]. In this four-domain DBL
structure, we replaced one of the EBA-175 F1 domains with
our VAR2CSA DBL3X model (Figure 5F). It was noticeable
that the largely conserved C2 and C4 regions of DBL3X were
predicted to take part in the lining of the central cavity of the
Figure 3. Multiple Alignment of VAR2CSA DBL3X Sequences
(A) cDNA from 43 placental parasite samples were amplified with conserved DBL3X primers and sequenced. Sequences were curated for primer
sequence, translated, and aligned. The text to the left indicates the identity of the samples. The DBL3X domain can be divided into four regions, which
are highly conserved, C1–C4; and three regions, which are polymorphic and harbor deletions V1–V3.
(B) Model of DBL3X showing the position of V1 (red), V2 (green), and V3 (orange).
doi:10.1371/journal.ppat.0020124.g003
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four-domain structure and form the region next to the cavity
facing the membrane in native conﬁguration. The model
presented here is unlikely to fatefully reﬂect the structure of
the native molecule, but the positioning of conserved DBL3X
regions in the model makes biological sense, and the ﬁnding
underscores the need to obtain knowledge about possible
interactions between VAR2CSA DBL domains. The lack of
amino acid positions under diversifying selection in the
regions adjacent to the cavity might be due to the possibility
that these sites are involved in ligand binding and thus
functional constraint. Another explanation could be that the
regions forming the predicted cavity and the area predicted
Table 1. Sequence Signature in DBL3X Position 158–162 of VAR2CSA Expressed by 42 Parasites Infecting either Primigravidae or
Multigravidae
Sequence Motif in DBL3X Primigravidae (n ¼ 21) Multigravidae (n ¼ 21)
EIEKD 16a 4
EIERE/EIEGE/GIERE 1 6
GIEGE 4 10
Gap 0 1
The motif ‘‘EIEKD’’ is overrepresented in primigravidae and underrepresented in multigravidae.
The intermediate motifs and ‘‘GIEGE’’ are mainly present in multigravidae.
One of the sequences from multigravidae contains a gap in the region.
aSignificantly higher represented in primigravidae, p , 0.001, Chi-square.
doi:10.1371/journal.ppat.0020124.t001
Figure 4. Sequence Differences in Infections with Different Parity
(A) Kullback-Leibler sequence logo based on a multiple alignment of the DBL3X region (Figure 3). The sequences in the alignment were split into two
groups of equal size: 21 sequences obtained from primigravidae and 21 sequences from multigravidae women. The x-axis shows amino acid positions
in the alignment. The height of a position indicates the amount of difference between the two groups according to the symmetric Kullback-Leibler
distance, and the letters indicate the amino acids contributing to this difference. The letter ‘‘O’’ has been chosen to signify gaps in the alignment. Polar
amino acids are green, basic are blue, acidic are red, and hydrophobic amino acids are black. P-values indicating the significance of DKL based on the
parity grouping compared to random groupings are shown below positions where p , 0.05.
(B) DBL3X model showing the position of amino acids that were differentially found in primi-gravidae and multigravidae women. Residues in the region
135–175 of moderately significant difference are shown in orange, and highly significant residues (positions 158, 161, and 162) are shown in red.
(C) The model (B) rotated 180 degrees so it is positioned similar to Figure 1C.
doi:10.1371/journal.ppat.0020124.g004
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to face the membrane are not accessible for antibodies in
natively folded molecules.
Recombination Is a Factor in the Generation of var2csa
Sequence Variation
Previous studies have reported that frequent recombina-
tion events generate sequence diversity in the PfEMP1 family
[26–28]. To determine the role of recombination for DBL3X
sequence variation, we estimated the population recombina-
tion rate q deﬁned for partially inbreeding haploid species by
the compound parameter 2Ner(1 f), where Ne represents the
effective population size, r is the per-generation cross-over
recombination rate per base pair (bp), and f is the inbreeding
coefﬁcient. Variations in q across DBL3X correspond to
variations in the recombination rate r, as Ne and f are
constant for the dataset. Two recombinational hotspots were
observed at bp positions 138–178 and 704–730 (Figure 5B).
The two best deﬁned recombination breakpoints were
present in the C1/V1 borderline at bp 177–179 and within
V3 at bp 728–730. Both the V1 and V3 region harbored major
deletions/insertions in several of the sequences, which may
Figure 5. Sequence Variation and B Cell Epitopes in DBL3
(A) dN/dS ratio per amino acid based on an alignment of 47 DBL3X sequences. dN/dS ratio higher than the dashed line indicates that the position is
under positive selection. V1–V3 and C1–C4 are indicated with solid bars. It should be noted that the inference of selection pressure is less reliable in
positions with gaps, which are mainly found in the variable regions (see Figure 3).
(B) The population recombination rate q ¼ 2Ner(1  f) estimated per bp across DBL3X. Circles indicate the SNPs for which q is estimated, linear
interpolation is shown between SNPs. Two hotspots corresponding to a local raise in r are observed in association with the variable regions V1 and V3.
(C) B cell epitope predictions of the 3D7 sequence performed by the BepiPred server. DD2 and IT-4 were used to fill 3D7 sequence gaps.
(D) Cartoon representation of the DBL3X model showing amino acid positions under diversifying selection in red (dN/dS ratios .1).
(E) DBL3X model with surface topography prediction showing amino acid positions under diversifying selection in red (dN/dS ratios .1).
(F) The homo-dimer of the two domains of RII of EBA-175 has been shown to form a handshake structure with F1 of one molecule dimerizing with F2 of
another molecule and vice-versa. Here VAR2CSA DBL3X has been superimposed on the F1 domain of one of the EBA-175 molecules in the dimer. The F1
domain is shown in green, F2 domains are blue, and the linker regions are gold. Amino acids under diversifying selection in DBL3X are shown in red
(dN/dS ratios .1). It is clear that most residues inward of the dimer are not under positive selection.
(G) DBL3X model showing residues with BepiPred scores higher than 0.9 in green. Locations of V1–V3 are indicated on the model. GB indicates the
glycan-binding site of EBA-175.
doi:10.1371/journal.ppat.0020124.g005
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have arisen as a consequence of unequal cross-over during
recombination at the hotspots. Unequal cross-over results in
either deletions or insertions of variable number of tandem
repeats (VNTR), and the DBL3X V1 region did indeed
contain a high amount of VNTR. The loop region of V2
contained a small VNTR insert in some sequences, while
VNTR were less obvious in the V3 region. In a recent study of
the P. falciparum Chromosome 3, high recombination rates
were found in sub-telomeric regions, and African P. falciparum
strains showed a much higher population recombination rate
than strains from other regions of the world [28]. The overall
population recombination rate for the DBL3X region was
estimated to q ¼ 0.54 per bp (95% CI: 0.41–0.90). This is in
accordance with a recent report for a VAR2CSA region
upstream to DBL3X around interdomain 1, where the rate
was estimated to 0.71 per bp [13], and in agreement with
recombination rates in Chromosome 3 of African parasite
lines summarized as q . 0.1 per bp [28]. The high population
recombination rate in DBL3X combined with the observed
sequence variation adjacent to the detected recombination
hotspots, suggests that recombination is an important factor
in generating sequence variation. The V1 region that seems to
be most strongly affected by recombination is predicted to
form a structurally unrestricted ﬂexible loop allowing for
sequence variation, and it is possible that the whole V1 region
is under diversifying selection pressure exerted by the
immune system, even though this could not be predicted by
the dN/dS method due to gaps. This notion is supported by
the ﬁndings discussed below, showing that this region is part
of a major B cell epitope.
VAR2CSA DBL3X B Cell Epitope Prediction
VAR2CSA epitopes exposed on the surface of the protein
and accessible for immunoglobulin gamma (IgG) binding
could be under diversifying selection resulting in escape
mutations and high dN/dS ratios, whereas residues involved
in protein folding, stability, and anchoring could be under
purifying selection with low dN/dS ratios. To predict linear B
cell epitopes, the 3D7 sequence was submitted to the
BepiPred server [29] and seven epitopes were predicted
within the DBL3X sequence (Figure 5C). Some of these
epitopes were located in areas with high dN/dS ratios and
there was a weak but statistically signiﬁcant association
between the BepiPred score and the dN/dS ratio (Pearson’s
r ¼ 0.18 and p ¼ 2.5*109). The reason for this weak
association could be that antibody epitopes are situated in
regions that are functionally constrained or that positive
selection pressure is also driven by other forces like MHC-2
binding and T helper cell activation as found for HIV-1 [30].
Furthermore, the BepiPred algorithm predicts linear epito-
pes, and some of these could be located in parts of the
molecule that are not accessible to antibodies in the native
folded molecule. Nevertheless, most of the predicted epitopes
(Figure 5G) were situated in surface-exposed loop regions of
the model, and one of the highest scoring epitopes was in the
V1 region. Residues that align directly to the glycan-binding
residues of EBA-175 F1 and to the Duffy antigen receptor for
chemokines (DARC) binding site in Pka-DBL were not
predicted to be part of epitopes. However, a part of the V2
region in proximity to the putative glycan-binding loop was
predicted to be targeted by antibodies and had high dN/dS
values.
Fine Epitope Mapping of VAR2CSA Antibodies Acquired
during Pregnancy
To verify the above bioinformatical predictions, we
evaluated the ﬁne speciﬁcity of naturally acquired human
antibodies to VAR2CSA DBL3X in a peptide array consisting
of 442 overlapping 31mer peptides covering exon 1 of
VAR2CSA of the 3D7 sequence. Antibody reactivity to
individual amino acids was assigned on the basis of an
algorithm based on the observation that a major part of
antibody binding motifs in a set of conformational epitopes
are from two to seven amino acids long, containing either two
or three deﬁned residues spaced by undeﬁned amino acids
[31]. The VAR2CSA of 3D7 contains 31,149 such motifs and
each was assigned an average PepScan value by adding the
measured reactivity from the 31mers in which the motif was
present, and dividing with the number of times the motif
occurred. The method, described in Materials and Methods,
was validated by testing serum from rabbits immunized with a
VAR2CSA construct, which showed that both the measure-
ments based on individual peptide readings and the
algorithm described above, mapped antibody responses to
regions present in the antigen used for immunization (Figure
S2). Furthermore, there was a high concurrence between
antibody peaks deﬁned by the reactivity of the individual
peptides and the peaks deﬁned by the algorithm deﬁning
single amino acid scores (Figure S2). Plasma from individuals
not exposed to malaria did not react with any of the peptides
in the array (unpublished data). The IgG reactivity in the
plasma of eight Ghanaian women with a known history of a
placental malaria infection was analyzed and the peptide
array data was visualized on the DBL3X model (Figure 6). The
regions with the highest reactivity were on the side of the
domain where glycan-binding is found in EBA-175 F1 (Figure
6A and 6B) and therefore IgG reactivity was visualized on a
model positioned with this side in the front (Figure 6A and
6C–I). It was clear that the majority of the individuals had
speciﬁc IgG against the variable regions, V1 or V2. V3 is
partly deleted in 3D7, and IgG reactivity could thus not be
measured in the peptide array based on the 3D7 sequence.
Remarkably, a short a-helix (Figure 6A, arrow 1) in proximity
to the loop for glycan-binding in EBA-175 F1 showed the
highest antibody reactivity in all serum samples, despite the
fact that this region had very low dN/dS ratios (Figure 5A,
positions 120–132). Another a-helix was also often recognized
by antibodies (Figure 6A, arrow 2). This helix was predicted to
contain a B cell epitope by the BepiPred algorithm and had
polymorphic residues (Figure 5A and 5C, positions 251–281).
The region corresponding to the loops containing the EBA-
175 F1 glycan-binding sites was not recognized by any of the
serum samples. Conserved regions (Figure 6A, arrow 1)
targeted by naturally acquired IgG are of considerable
interest in the search for vaccine constructs which could
elicit a broad protective immune response.
PepScan Analysis of Affinity-Purified Antibodies
During infection, VAR2CSA will be degraded and anti-
bodies will be acquired against epitopes that are not
accessible for antibodies when the protein is in its natural
conformation. It is therefore possible that some of the
antibody reactivities measured in the peptide array were
directed against such epitopes. To address this question,
analysis was performed on plasma, which had been afﬁnity
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puriﬁed on recombinant DBL3X or antibody-depleted by
incubation with erythrocytes infected with VAR2CSA-ex-
pressing parasites.
Plasma from a rabbit immunized with recombinant DBL3X
and plasma from women who had suffered a placental
infection were afﬁnity puriﬁed on the recombinant CSA-
binding DBL3X protein and analyzed by the peptide array.
Before afﬁnity puriﬁcation, the plasma pool from Ghanaian
women showed reactivity corresponding to eight peaks
distributed throughout the domain (Figure 7A). In contrast,
the reactivity of the afﬁnity-puriﬁed IgG was concentrated to
three peaks (SE1–SE3) in the C1, V1, and C2/V2 regions. The
immunized rabbit had strong IgG reactivity against the
epitope in the C2/V2, which was also afﬁnity puriﬁed from
the female plasma pool (Figure 7B), but the rabbit had not
raised an IgG response against the epitopes in C1 and V1. A
plasma pool from Tanzanian women was also analyzed and in
this case surface reactive antibodies were depleted from the
pool by incubation with VAR2CSA-expressing infected
erythrocytes. In this pool the main reactivity was against the
surface-exposed epitopes (SE1–SE3) deﬁned in the Ghanaian
plasma, and the depletion experiment indicated that absorp-
tion with infected erythrocytes caused a marked reduction in
the reactivity against these epitopes (Figure 7C). These
ﬁndings indicate that the three identiﬁed regions were
accessible to antibodies on the native protein and that the
folding of the Baculovirus-produced recombinant protein was
close to the natural conﬁguration. SE2 and SE3 corresponded
to loop regions V1 and V2, which are both protruding from
the structure of the DBL3X model (Figure 7D). Interestingly,
SE1 and SE3, which are located in separate parts of the
primary structure of the domain, form a continuous region
Figure 6. Defining Targets of Antibodies on DBL3X
Models of DBL3X in which the intensity of the gray and blue indicates reactivity of plasma tested on a peptide array (PepScan scores). Gray indicates
lowest scores and dark blue indicates highest scores. (A and C–I) represent reactivity in eight individual plasma samples. (B) shows the reactivity in the
same plasma as tested in (A), but the model has been rotated 180 degrees. Arrow 1 indicates a highly recognized conserved a-helix region, which was
not predicted to be an epitope by BepiPred and was characterized by low dN/dS ratios and low sequence variation. Arrow 2 indicates another a-helix
with a predicted B cell epitope containing some residues with high sequence variation. Variable regions V1 and V2 are fairly well recognized by most of
the serum samples. GB indicates the glycan-binding site of EBA-175.
doi:10.1371/journal.ppat.0020124.g006
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Figure 7. Reactivity of Plasma Affinity Purified on Recombinant DBL3X and Human IgG Depleted for Surface Reactivity by Incubation with Infected
Erythrocytes Expressing VAR2CSA
(A) PepScan IgG reactivity in a Ghanaian pool of pregnancy plasma before (red) and after (blue) affinity purification on recombinant DBL3X protein.
Variable regions V1 and V2 are indicated with a black line. Arrows indicate three surface-exposed regions (SE). The x-axis is amino acid position in 3D7
VAR2CSA.
(B) PepScan IgG reactivity in plasma from a rabbit immunized with DBL3X before (red) and after (blue) affinity purification on recombinant DBL3X
protein. Arrow indicates the surface-exposed region. N- and C-terminal parts of the recombinant proteins did also appear to be surface-exposed; this
could be due to improper folding of the N- and C-terminal parts of the protein.
(C) PepScan IgG reactivity in a Tanzanian pool of pregnancy plasma before (red) and after (blue) depletion of antibodies directed against surfaced-
exposed VAR2CSA regions by incubation with infected erythrocytes expressing VAR2CSA on the surface. Arrows indicate three regions where the
reactivity was markedly reduced after depletion largely corresponding to SE1, SE2, and SE3 on (A).
(D) DBL3X model showing the location of surface-exposed epitopes, SE1 (blue), SE2 (red), and SE3 (green).
(E) DBL3X surface topography showing SE1–SE3. From the model it is apparent that the SE1 and SE3 form a continuous epitope.
(F) VAR2CSA DBL3X superimposed on the F1 domain of one of the molecules in the EBA-175 dimer. The F1 domain is shown in green, F2 domains are
blue, and the linker regions are gold. On the DBL3X domain the three experimentally verified surface-exposed regions are shown in similar coloring as
(D and E) The three regions are mainly predicted to be on the opposite side of the central cavity of the dimer, and parts of SE3 correspond to amino
acid positions directly involved in the dimerization of EBA-175.
doi:10.1371/journal.ppat.0020124.g007
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on the surface of the predicted DBL3X protein structure
(Figure 7E). The model also predicts that all surface-exposed
sites are located on one part of the domain indicating that
the other parts are buried or engaged in the intact PfEMP1
molecule expressed on the surface of the infected erythrocyte
(Figure 7E). Unexpectedly, the highly conserved part of C2,
which was well recognized in the peptide array by all women,
corresponded to a part of the surface-exposed epitope SE3.
When exchanging the F1 domain of one of the EBA-175
molecules in the EBA-175 dimer with VAR2CSA DBL3X and
mapping SE1–SE3 to the model, it is apparent that the
surface-exposed regions are on the opposite side of the
central cavity of the dimer (Figure 7F). However, the part of
DBL3X that may be directly involved in the dimerization
extends into the SE3 region (shown in green), indicating that
in this model the potential dimerization motifs are accessible
for antibodies. EBA-175 is suggested to dimerize upon ligand
interaction and it could be that SE3 was ‘‘unengaged’’ due to
the lack of CSA during antibody depletion. If several domains
need to interact to form a buried CSA-binding site, anti-
bodies targeting conserved residues, like the region in C2 that
forms parts of SE3, could function by inhibiting the
dimerization of domains.
Our results demonstrate that both conserved and poly-
morphic surface-exposed regions are targets for VAR2CSA
DBL3X antibodies acquired during pregnancy by malaria-
infected women. This opens for vaccine, strategies similar to
those being pursued for the polymorphic merozoite surface
protein (MSP) 1 [32]. The proteolytic processing of MSP1 is a
prerequisite for successful parasite invasion of erythrocytes,
and one vaccine strategy is based on the induction of
antibodies against the conserved C-terminal part of the
molecule that inhibits processing [33]. Another MSP1 vaccine
strategy employs chimeric vaccine constructs designed to
induce antibodies targeting the polymorphic types present in
the N-terminal part of the molecule [34]. In a similar fashion,
VAR2CSA vaccine constructs could target conserved epitopes
like those identiﬁed in SE3, or alternatively, constructs should
induce antibodies targeting different serological variants like
those predicted to be generated by the sequence poly-
morphisms present in regions SE1 and SE2. The human
antibody pools used in this study to identify surface-exposed
antigenic targets inhibit parasite binding to CSA in vitro
(unpublished data). However, the molecular targets of the
inhibitory antibodies have not been identiﬁed and knowledge
is required about the antigenic targets for antibodies on the
other VAR2CSA DBL domains. The high similarity between
the DBL structures of EBA-175 [15], Pka-DBL [16], and the
VAR2CSA DBL3X model suggests that the DBL structures in
Plasmodium are relatively conserved and that the antigenic
characteristics of the DBL3X might be comparable to those of
the remaining VAR2CSA DBL domains. However, a more
comprehensive analysis of sequence variation, antibody
epitopes, and structure of the VAR2CSA DBL domains not
belonging to DBL3X is needed to establish the extent of the
structural conservation between the domains.
Development of PAM vaccines requires a much better
understanding about the molecular interaction between
placental parasites and the ligand on the syncytiotropho-
blasts, as well as knowledge about the ﬁne speciﬁcity of the
targets for antibodies inhibiting binding. Native PfEMP1
molecules are difﬁcult to isolate and with current technolo-
gies it is difﬁcult to produce correctly folded recombinant
material in quantities allowing structure elucidation by
crystallography. In this paper, we have combined in silico
methods such as model building and sequence analysis and
the analysis of antibody reactivity to obtain new information
and generate hypotheses about the structure and functional
relationship of VAR2CSA.
Materials and Methods
Cloning and expression of VAR2CSA domains. DBL3X and DBL4e
of VAR2CSA were ampliﬁed from FCR3 and 3D7 genomic DNA with
the following primers: FCR3 DBL3X – 59 CG GAA TTC ACC AAT
ATT AAT AAA AGT GAA and 39 ATT TGC GGC CGC CAG CAT
TAT TAT ATT TGT A, 3D7 DBL3X – 59CG GAA TTC AAG ATG
AAG TCC TCC GAG and 39ATT TGC GGC CGC CAA AAC AGC
CAA GCT GGA, 3D7 DBL4e - 59CG GAA TTC CAG GTG AAG TAC
TAC GAA and 39CTG TTC CTC CAC GTG CTC CAG. PCR products
were digested with EcoRI and NotI for cloning into the Baculovirus
vector, pAcGP67-A (BD Biosciences, http://www.bdbiosciences.com),
which was modiﬁed to contain the V5 epitope upstream of a histidine
tag in the C-terminal end of the constructs. Linearised Bakpak6
Baculovirus DNA (BD Biosciences) was co-transfected with pAcGP67-A
into Sf9 insect cells for generation of recombinant virus particles.
Recombinant protein was puriﬁed on Co2þ metal-chelate agarose
columns as secreted histidine-tagged proteins from the supernatant
of infected High-Five insect cells.
CSA binding assay. Binding to CSA (C9819, Sigma-Aldrich, http://
www.sigmaaldrich.com) was determined in an ELISA system. ELISA
plates (Falcon 351172) were coated overnight with CSA (50 lg/ml) in
PBS at 4 8C. Coating with 1% BSA in PBS (blocking buffer) was used
as negative control. Plates were incubated with blocking buffer for 1 h
at room temperature (RT) to inhibit non-speciﬁc adsorption to the
plate. The VAR2CSA proteins were diluted in blocking buffer (1–10
lg/ml protein), added to the wells, and incubated for 1 h at RT. For
the inhibition assays, proteins (7 lg/ml) were pre-incubated with
different concentrations of soluble CSA for 30 min. Plates were
washed four times in PBS between the different steps. Speciﬁc
binding was visualized by adding an HRP-conjugated antibody (R960–
25, Invitrogen, http://www.invitrogen.com) targeting the V5 epitope
of the constructs. Plates were incubated for 1 h with the anti-V5
antibody diluted 1:3000 in blocking buffer. The color reactions were
developed for 15 min by the addition of o-phenylenediamine
substrate and stopped by adding 2.5 M H2SO4. The optical density
was measured at 490 nm.
Cloning and sequencing of placental var2csa genes. All DBL3X
sequences were obtained from cDNA, whereas DBL2X and the
overlapping region of DBL4e and DBL5e of var2csa were cloned from
genomic DNA of placental parasites. In brief, parasites were dissolved
in Trizol LS (Invitrogen) and RNA was prepared according to the
manufacturer’s instruction. RNA pellets were dissolved in 10 ll of
RNase-free water and treated with DNaseI (Sigma-Aldrich) for 25 min
at RT, followed by 10 min heat inactivation at 65 8C. All RNA samples
were subsequently tested in real-time PCR for contamination with
genomic DNA using a primer set for the housekeeping gene, seryl-
tRNA synthetase. DNA-free RNA samples were used for synthesis of
cDNA by reverse transcriptase (Superscript II, Invitrogen) and
random hexamer primers as described by the manufacturer.
Following primer sets were used for cloning DBL3X from cDNA
into either the Baculovirus vector, pAcGP67-A (BD Biosciences) or the
pCR2.1-TOPO vector (Invitrogen): p509 59 CG GAA TTC GAT ACA
AAT GGT GCC TGT and p510 39 ATT TGC GGC CGC ATA TAC
TGC TAT AAT CTC C, p508 59 CG GAA TTC ACA CAA AAT TTA
TGT GTT and p510, p503 59 GAG ATA CAA ATG GTG CCT GT and
p505 39 AAA TTT GCT GAT ATA CAT TCA G. PCR products aimed
for the Baculovirus vector were digested with EcoRI and NotI before
ligation. Three to six colonies of each cloning and corresponding
plasmids were sequenced by Macrogen (http://www.macrogen.com).
Genomic DNA was extracted from ﬁlter paper using a chelex-
based method [35]. Brieﬂy, ﬁlter spots were dissolved in 0.5% saponin
in PBS using a microtiter plate and incubated overnight on a shaker
at RT. After washing the ﬁlter spots twice in PBS, a solution of 50 ll of
H2O and 100 ll of 10% chelex mixture was added to each well. The
plate was boiled for 8 min and subsequently cooled down for 10 min
at RT. A PCR reaction was run with primers for the seryl-tRNA
synthetase gene to control for the DNA content. Around 1–3 ll of DNA
was used for the PCR reactions amplifying the different var2csa
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regions. All PCR products were cloned into the pCR2.1-TOPO vector
and the inserts sequenced on a 3100-Avant Genetic Analyzer (Applied
Biosystems, http://www.appliedbiosystems.com). The origin of para-
sites are described in [20].
Phylogenetic reconstruction. The alignment of 43 placental and
four database VAR2CSA DBL3X sequences, covering the 3D7 amino
acid positions 1256–1549, was constructed using the software
RevTrans [36], and subsequently manually corrected for errors. To
cover more of the DBL3X domain, an alignment of 17 database
sequences was constructed in the same way, covering the 3D7
positions 1217–1255. For the phylogenetic tree, 21 Malawian
sequences [21] were aligned with the sequences mentioned above,
again using RevTrans and manual correction, resulting in a 609-bp
alignment. The program MrModeltest version 2.2 [37] was used to
ﬁnd the most appropriate nucleotide substitution model based on the
Akaike information criterion [38]. Phylogenetic trees based on the
above alignments were constructed by Bayesian inference using the
program MrBayes version 3.1.1 [39]. In all cases Markov chain Monte
Carlo (MCMC) sampling was performed for 10,000,000 generations
with eight chains. Convergence was conﬁrmed by comparing the
results of two independent runs. Burn-in was determined using
Tracer [40] and 50% majority rule consensus trees were constructed.
Model ﬁtting and Akaike weighted dN/dS average. The program
codeml from the PAML package version 3.14 [41] was used to ﬁt a
range of codon-based evolutionary models to the VAR2CSA DBL3X
region using the alignments and Bayesian trees mentioned above. The
11 codon-based models were tested using codeml: M0, M1a, M2a, M3
(with either 3, 4, 5, 6, or 7 site categories), M5, M7, and M8 [42–44]. All
11 models were ﬁtted using the F3x4 (different nucleotide frequen-
cies for each codon position) approach for estimating codon
frequencies. Convergence was conﬁrmed by comparing the results
of several independent runs started with different parameter vectors.
The Akaike information criterion (AIC) was used to assess model
ﬁts [38,45,46]. Brieﬂy, AIC estimates the expected relative Kullback-
Leibler distance (i.e., AIC is an estimate of the amount of information
that is lost when a given model is used to approximate the full truth).
AIC is a function of the maximized log-likelihood (lnL) and the
number of estimated parameters (K) for a model. Speciﬁcally, AIC¼
2lnLþ 2K where lower AIC values indicate better models. From AIC
it was possible to compute Akaike weights, which can be interpreted
as the conditional probability of the model given the data and the set
of initial models [38,46]. On this basis, dN/dS ratios for codon
positions were calculated as an average of the dN/dS ratios estimated
from each of the 11 models, weighted by the Akaike weights for the
corresponding model.
Recombination and mutation rates, diversity, and sequence logo
creation. The population recombination rate q was estimated for the
VAR2CSA DBL3X domain in LDhat version 2.0 [47], which based on
population genetics uses coalescent methods specially adapted to
account for the possibility of recurrent or back mutation and for an
AT-rich genome such as that of P. falciparum [48]. As argued byMu et al.
[28], the coalescent recombination estimate can, for partially inbreed-
ing haploid species such as P. falciparum, be interpreted as the
compound parameter q¼2Ner(1f), where Ne represents the effective
population size of the DBL3X population, r denotes the rate of
recombination cross-over events per generation per bp, and f is the
inbreeding coefﬁcient. The effective population size should be thought
of as the size of an ideal population [48,49] with the samemagnitude of
random genetic drift as the actual population with size N [50].
To test if the placental DBL3X sequence data showed evidence for
deviation from the neutral model of evolution assumed by the
coalescent method, we calculated Tajima’s D statistic [51] and Fu and
Li’s D* and F* statistic [52]. All three statistics were insigniﬁcantly
different from zero (p . 0.1 in all cases), indicating that the
coalescent approach could be applied. The hypothesis of no
recombination was rejected using the likelihood permutation test
[48] with 1,000 permutations of segregating sites, of which none
produced a higher maximum composite likelihood than for the
DBL3X data. The hypothesis of a constant recombination rate across
the analyzed region was also rejected (p ¼ 0.048 with 10,000
simulations) using the method described in [47], indicating signiﬁ-
cance in the recombination rate variations over DBL3X.
For calculation of the population recombination rate q, we used
the Bayesian reversible-jump Markov chain Monte Carlo (RJMCMC)
method with a block penalty of 10, running for 10,000,000 iterations
with 2,000 iterations per sample and a burn in of 50 samples. The
overall region estimate was converted to bp units using the average
length of the analyzed sequences. Recombination hotspots were
deﬁned as intervals containing SNPs where the population recombi-
nation rate mean was above the upper limit of the 95% conﬁdence
interval for the overall region estimate of 2Ner(1 f). Fu and Li’s D*
and F* and Tajima’s D were calculated using DnaSP version 4.10.6
[53]. The average nucleotide diversity and its variance were calculated
according to Nei [54] equation 10.5 and 10.7, respectively (gapped
columns were included).
The Kullback-Leibler sequence logo was created by calculating the
distance between the two groups of sequences for each amino acid
position in the alignment using the symmetric Kullback-Leibler
distance:
DKL ¼
X
AA
ðp p9Þ  log p
p9
 
ð1Þ
where p and p9 are the frequencies of an amino acid type in each of
the two groups, and AA indicates that the sum is over all the amino
acid types. The cumulated Kullback-Leibler distance was calculated as
the sum of Dkl for all positions in the alignment. Gaps in the
alignment were in this analysis assigned the letter ‘‘O’’ and treated as
an amino acid class. To test if the mentioned grouping according to
parity gave two signiﬁcantly different sequence groups, we created
10,000 random groupings and for each of these summed the DKL over
all amino acid positions. Similarly for the individual positions in the
logo, the distribution of DKL for 10,000 random shufﬂes of sequence
grouping was noted speciﬁcally for each position, and the p-values
were based on these distributions.
PepScan motif analysis. 442 overlapping 31mer peptides covering
the exon 1 of 3D7 VAR2CSA were synthesized as solid phase peptide
synthesis (SPPS) with a stepwise addition of the different amino acids
attached to a solid resin. The long peptides were synthesized with a
cysteine at amino acid (aa) position 15 allowing some secondary
structure. This approach allows identiﬁcation of antigenic sites that
cannot be mapped using short, linear peptides (PepScan Systems, the
Netherlands). The raw data from a PepScan experiment consists of
ﬁgures measuring the amount of IgG bound to each of the overlapping
31mer peptides. We used the overlap in primary sequence to
determine more speciﬁcally what the antibodies have afﬁnity for.
The motif analysis is based on the concept that polyclonal IgG
response consists of subpopulations of monoclonal antibodies each
binding a certain set of amino acid sequence motifs. We then made a
list of all possible binding motifs and transferred the information
from the peptide array to these, giving each motif a score indicating
the IgG afﬁnity for the motif. The PepScan assay is designed primarily
to determine linear epitopes, and thus we are mainly interested in
short binding motifs and gaps. On this basis we performed the
PepScan motif analysis, using motifs containing either two or three
deﬁned residues spaced by undeﬁned amino acids up to a certain
maximal length of 5, 7, 10, 15, 20, or 25 residues. We found that the
different maximal motif lengths gave similar results, but with
different detail resolutions (long motifs had a smoothing effect),
and a binding motif with a maximal length of seven residues was
selected as being most informative. Thus, the presented results are
based on the assumption that motifs are two to seven amino acids
long, and contain either two or three deﬁned residues spaced by
undeﬁned amino acids, e.g., a possible motif could be ‘‘WXXXDXE’’
or simply ‘‘KN.’’ The method was validated by comparison to the raw
data, where rabbit serum from a rabbit immunized with a DBL5
construct was used in the PepScan assay (Figure S2). The ﬁgure shows
that the motif analysis produces peaks approximately at the same
positions as in the raw data, and that the analysis does not introduce
bias in the other regions of the protein. As control for the human IgG
used in Figure 6, we used non-immune Dutch serum as well as a
malaria-exposed nulliparous female individual.
Afﬁnity puriﬁcation of antibodies and depletion of serum on
parasites. Afﬁnity puriﬁcation of antibodies was done according to
manufacturer’s instructions. In brief, 1 mg of recombinant protein
was dialyzed against 0.2 M NaHCO3, 0.5 M NaCl (pH 8.3), and applied
to a NHS-activated HiTrap 1-ml column (GE Healthcare, http://www.
gehealthcare.com) that had been equilibrated with 332 ml 4 8C 1 mM
HCl. After coupling, the columns were washed with 0.5 M ethanol-
amine, 0.5 M NaCl (pH 8), 0.1 M acetate, 0.5 M NaCl (pH 4), and a ﬁnal
wash with PBS (pH 7.4). 1 ml of a plasma pool (28 women from
Ghana) was then applied to the column. After washing in 10 ml PBS,
afﬁnity-bound antibodies were eluted by CH3COONH4 (pH 3) and
neutralized in 1 M Tris (pH 7.5). The speciﬁcity of the puriﬁed
antibodies was tested in ELISA against (1) the domain used for
afﬁnity puriﬁcation, (2) other VAR2CSA domains, and (3) glutamine
rich protein (GLURP) [55]. Afﬁnity-puriﬁed antibodies used for
PepScan analysis were all negative in ELISA against control proteins
and positive against the homologous domain (unpublished data).
Surface reactive antibodies in a pool of pregnancy plasma (from 15
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pregnant women from Korogwe, Tanzania) were depleted using a
parasite line selected for VAR2CSA expression using VAR2CSA
speciﬁc antibodies [9]. In brief, 40 ll of the plasma pool were
incubated with 2.03 108 MACS puriﬁed intact late stage trophozoite-
and schizont-infected erythrocytes for 20 min at 4 8C. Hereafter, the
cells were centrifuged at 800 g for 8 min, and the supernatant used to
suspend a new pellet of 2.0 3 108 infected erythrocytes. This
procedure was repeated four times. The depletion of surface reactive
antibodies from the plasma pool was conﬁrmed using a ﬂow
cytometry assay [9] after the ﬁnal depletion.
3-D modeling of the 3D7 DBL3X domain. The 3-D structure of the
3D7 sequence (PFL0030c aa 1217–1559) was modeled using the
HHpred server with default settings [56]. Brieﬂy, the HHpred method
is specialized in remote homology detection using hidden Markow
models (HMMs) built from PSI-BLAST proﬁles and secondary
structure. The crystal structure of EBA-175 F1 (Protein Data Bank
code 1ZRO chain A, [15]) was used as template and had the highest
sequence and secondary structure alignment scores. The HHpred
alignment was corrected in a short template loop sequence (Figure S1,
positions 215–219) positioned next to a gap. The correction shifted
the position of the gap and allowed for the modeling of a disulﬁde
bridge in DBL3X, which was conserved in the EBA-175 F1, F2, and
Pka-DBL domains. HHpred HMMs for DBL3X and the template
continued to match. Finally the corrected alignment was used to
generate a 3-D model using MODELLER [57] with the protocol setup
in the HHpred server toolkit. A superimposition of the EBA-175 F1
structure and the DBL3X model was obtained by the HHpred toolkit.
Naccess version 2.1.1 [58] was used to calculate relative surface-
exposed areas (RSAs) in single chains of EBA-175 F1, F2, and the Pka-
DBL domain [16]. The MAMMOTH-mult alignment server [59] was
used to make a multiple structure superimposition of DBL3X model
on the EBA-175 F1 and F2 DBL domains [15] and the Pka-DBL domain
[16]. The resulting alignment was inspected to identify conserved
positions of cysteines and buried hydrophobic residues (RSA, 30%).
Structural visualizations were made using PyMol [60].
Supporting Information
Figure S1. Multiple Structural Alignment of VAR2CSA DBL3X, EBA-
175 F1, EBA-175 F2, and Pka-DBL
Cysteines in conserved disulﬁde bonds are highlighted in blue,
conserved tryptophans buried in the structures are shown in red, and
other conserved, buried, and hydrophobic positions are shown in
green.
Found at doi:10.1371/journal.ppat.0020124.sg001 (51 KB PTT).
Figure S2. PepScan Analysis of Rabbit Serum Immunized with a DBL5
Recombinant Construct
(A) Plasma from a rabbit immunized with a DBL5 construct was
tested in 1:1000 on the VAR2CSA PepScan array. The upper diagram
is the raw PepScan values with the PepScan score (y-axis) for each of
the 420 peptides (x-axis).
(B) The same PepScan scores as (A) but calculated using a motif
algorithm assigning a value to each amino acid.
Found at doi:10.1371/journal.ppat.0020124.sg002 (160 KB PPT).
Accession Numbers
All sequence data are available at GenBank (http://www.ncbi.nlm.nih.
gov/Genbank) under the accession numbers DQ995590–DQ995632.
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